Targeted Opioid Receptor Antagonists in the Treatment of Alcohol Use Disorders Mark J. NiciuAlbert J. Arias Leading Article 24 July 2013 Pages: 777 - 787
Current Place of Monoamine Oxidase Inhibitors in the Treatment of Depression Kenneth I. ShulmanNathan HerrmannScott E. Walker Leading Article 10 August 2013 Pages: 789 - 797
Neuroprotection in Multiple Sclerosis: A Therapeutic Approach Amir-Hadi MaghziAlireza MinagarEmmanuelle Waubant Review Article 17 August 2013 Pages: 799 - 815
Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy Warrington W. Q. HsuC. W. SingEsther W. Chan Systematic Review Open access 07 August 2013 Pages: 817 - 827
Health-Related Quality of Life and Functional Outcomes from a Randomized, Controlled Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention Deficit Hyperactivity Disorder Tobias BanaschewskiCésar SoutulloDavid Coghill Original Research Article Open access 28 July 2013 Pages: 829 - 840
Modelling the Risk of Visual Field Loss Arising from Long-Term Exposure to the Antiepileptic Drug Vigabatrin: A Cross-Sectional Approach John M. WildDavid L. FoneGareth D. Lewis Original Research Article 30 August 2013 Pages: 841 - 849
Extended-Release Intramuscular Naltrexone (VIVITROL®): A Review of Its Use in the Prevention of Relapse to Opioid Dependence in Detoxified Patients Yahiya Y. SyedGillian M. Keating Adis Drug Evaluation 10 September 2013 Pages: 851 - 861
Comment on: “Management of Alcohol Dependence in Patients With Liver Disease” Benjamin RollandSylvie DeheulRégis Bordet Letter to the Editor 03 September 2013 Pages: 863 - 864
Authors’ Reply to Rolland et al.: “Management of Alcohol Dependence in Patients with Liver Disease” Giovanni AddoloratoAntonio Mirijello Letter to the Editor 03 September 2013 Pages: 865 - 866